Duvoglustat

Generic Name: Duvoglustat

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₆H_₁₃NO_₄

CAS Number: 19130-96-2

Unique Ingredient Identifier: FZ56898FLE

Background: An alpha-glucosidase inhibitor with antiviral action. Derivatives of deoxynojirimycin may have anti-HIV activity.

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Drug-drug Interaction Study

Phase 2

Completed

Conditions: Pompe Disease

Interventions: Drug: duvoglustat
Drug: rhGAA

First Posted Date: 2011-06-27

Last Posted Date: 2024-07-31

Lead Sponsor: Amicus Therapeutics

Target Recruit Count: 25

Registration Number: NCT01380743

Study to Evaluate the Safety of AT2220 (Duvoglustat) in Pompe Disease

Phase 2

Terminated

Conditions: Pompe Disease

Interventions: Drug: Duvoglustat

First Posted Date: 2008-06-03

Last Posted Date: 2018-08-17

Lead Sponsor: Amicus Therapeutics

Target Recruit Count: 3

Registration Number: NCT00688597

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy